GSK and Novartis on Thursday reinforced commitments to address neglected tropical diseases, as world leaders and health experts gather in Rwanda to discuss ways to better combat illnesses affecting more than a billion people, mostly in impoverished communities. The intention is to spur a renewed effort to address some 20 diseases that have been eradicated in the developed world – …
Read More »GSK, NOVARTIS PLEDGE FUNDS FOR DISEASES THAT MOSTLY AFFECT THE POOR
June 24, 2022